News from China
Updates every hour. Last Updated: 20-Dec-2025 08:11 ET (20-Dec-2025 13:11 GMT/UTC)
Mineral secrets revealed: Iron nanoparticles drive the breakdown of plastic additives
Maximum Academic PressPeer-Reviewed Publication
New study reveals climate and soil controls on nitrous oxide emissions across the Eurasian steppeIntroduction
Maximum Academic PressPeer-Reviewed Publication
Scientists reveal how tumor-cell MHC-II drives immunotherapy success
China Anti-Cancer AssociationPeer-Reviewed Publication
- Journal
- Cancer Biology & Medicine
Carbon dioxide stunning boosts pork tenderness by reshaping muscle cell pathways
Maximum Academic Press- Journal
- Food Materials Research
New UV-triggered packaging technology extends shelf life of chilled meat
Maximum Academic Press- Journal
- Food Materials Research
CRISPR-edited pig stem cells pave way for large-scale lab-grown meat
Maximum Academic PressA research team has developed a serum-free system combined with CRISPR/Cas gene editing that enables long-term expansion and efficient muscle differentiation of porcine satellite cells, laying the foundation for scalable and sustainable cultured meat production.
- Journal
- Food Materials Research
Winter symptoms mask early cancer signs in men
BGI GenomicsChinese Neurosurgical Journal study reveals high paralysis risk in corticospinal tract-infiltrating gliomas
Chinese Neurosurgical JournalPeer-Reviewed Publication
Researchers at Beijing Tiantan Hospital analyzed 101 glioma cases involving the brain’s motor pathway and found that one-third of patients developed permanent paralysis after surgery. High tumor grade, pre-operative motor deficits, and larger tumor volume were key predictors. The work underscores the need for precise imaging and careful surgical planning to maximize survival while safeguarding motor function.
- Journal
- Chinese Neurosurgical Journal
- Funder
- Capital Health Development Scientific Research Project
Multi‑target disease‑modifying strategies for Alzheimer’s disease: guided by a comprehensive biomarker framework
Science China PressPeer-Reviewed Publication
Alzheimer’s disease (AD) imposes a substantial clinical and societal burden, yet currently approved symptomatic therapies do not modify the underlying disease biology. Recently, three anti-amyloid monoclonal antibodies (aducanumab, lecanemab, and donanemab) have demonstrated robust amyloid clearance. Their clinical effects are statistically significant but modest, underscoring the need for broader, biologically informed strategies. Guided by the 2024 Alzheimer’s association ATNIVS biomarker framework, a team form Xuanwu Hospital, Capital Medical University synthesizes disease-modifying therapies (DMTs) targeting amyloid (A), tau (T), neurodegeneration (N), inflammation (I), vascular injury (V), and α-synuclein (S), summarizing the candidate therapies for each target, explain the mechanisms of action and pivotal clinical trial results. The review is currently published on the journal Medicine Plus.
- Journal
- Medicine Plus